New synthesis of (+)-(S)-halothane

Chirality

Volumn 8, Issue 1, 1996, Pages 3-5

  Rozov, Leonid A ^a   Ramig, Keith ^a  

^a Ohmeda Inc   (United States)

Author keywords

asymmetric synthesis; halothane; inhalational anesthetic; stereospecific decarboxylation

Indexed keywords

2 BROMO 2 CHLORO 3,3,3 TRIFLUOROPROPIONIC ACID; AMMONIUM DERIVATIVE; CATION; HALOTHANE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DECARBOXYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0029868905     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1996)8:1<3::AID-CHIR2>3.0.CO;2-M     Document Type: Conference Paper

References (25)

1. Halpern, D. F. Fluorinated inhalation anesthetics. In: Organofluorine Chemistry Principles and Commercial Applications. Banks, R. E., Smart, B.E., Tatlow, J.C., eds. New York: Plenum Press, 1994:543-554 (review).
2. Martin, J.L., Dubbink, D A., Plevak, D.J., Peronne, A., Taswell, H.F., Hay, E.J., Pumford, N. R., Pohl, L.R. Halothane hepatitis 28 years after primary exposure. Anesth. Analg. 74:605-608, 1992. Ellis, F.R. Is the K-type caffeine-halothane responder susceptible to malignant hyperthermia? Br. J. Anaesth. 69:468-470, 1992.
3. Martin, J.L., Dubbink, D A., Plevak, D.J., Peronne, A., Taswell, H.F., Hay, E.J., Pumford, N. R., Pohl, L.R. Halothane hepatitis 28 years after primary exposure. Anesth. Analg. 74:605-608, 1992. Ellis, F.R. Is the K-type caffeine-halothane responder susceptible to malignant hyperthermia? Br. J. Anaesth. 69:468-470, 1992.
4. Knabe, J., Agarwal, N. S. Über Versuche zur Gewinnung von optisch aktivem halothan. Dtsch. Apoth. Ztg. 113:1449-1453, 1973. Wilen, S. H., Bunding, K.A., Kascheres, C.M., Wieder, M.J. On the optical activity of bromochlorofluororaethane. J. Am. Chem, Soc. 107:6997-6998, 1985.
5. Knabe, J., Agarwal, N. S. Über Versuche zur Gewinnung von optisch aktivem halothan. Dtsch. Apoth. Ztg. 113:1449-1453, 1973. Wilen, S. H., Bunding, K.A., Kascheres, C.M., Wieder, M.J. On the optical activity of bromochlorofluororaethane. J. Am. Chem, Soc. 107:6997-6998, 1985.
6. Edamura, F.Y., Larsen, E.R., Peters, H.M. Preparation of Optically Active Halothane. Abstracts of Papers, 159th American Chemical Society National Meeting, 1970, abstract ORGN 84.
7. Pearson, D. L. The Synthesis of Enantiomerically Pure Inhalational Anesthetics-Halothane and Enflurane. Ph.D. Dissertation, Cornell University, 1990.
8. (a) Cascorbi, H.F., Morgan, P.G., Sedensky, M.M. Halothane's potency is stereospecific. Abstracts of Scientific Papers, 1994 Meeting of the American Society of Anesthesiologists, abstract A440 (see: Anesthesiology 81(Suppl) 1994).
9. (a) Cascorbi, H.F., Morgan, P.G., Sedensky, M.M. Halothane's potency is stereospecific. Abstracts of Scientific Papers, 1994 Meeting of the American Society of Anesthesiologists, abstract A440 (see: Anesthesiology 81(Suppl) 1994).
10. (b) Moody, E.J., Harris, B.D., Skolnick, P. The potential for safer anaesthesia using stereoselective anaesthetics. Trends Pharmacol. Sci. 5:387-391, 1994.
11. Other syntheses of non-racemic fluorinated anesthetics: Rozov, L.A., Huang, C.G., Halpern, D.F., Vernice, G.G. Preparation of purified optical isomers of desflurane. U.S. Patent 5 283 372, 1994 (Anaquest). Huang, G.G., Rozov, L.A., Halpem, D.F., Vernice, G.G. Preparation of the isoflurane enantiomers, J. Org. Chem. 58:7382-7387, 1993. Two patents (Young, J.W., Brandt, S. U.S. 5 114 714, 1992, and U.S. 5 114 715, 1992; filing date 11/29/90) have been issued to Sepracor (Marlborough, MA) claiming the synthesis and use of optically enriched isoflurane and desflurane. These patents, both of which are entirely devoid of experimental detail, physical characterization, and pharmacological data, were filed after Ohmeda's (formerly Anaquest) patent application (USSN 07/ 550,417; filed 7/10/90) describing full physical characterization and pharmacological testing of the enantiomers of isoflurane.
12. Other syntheses of non-racemic fluorinated anesthetics: Rozov, L.A., Huang, C.G., Halpern, D.F., Vernice, G.G. Preparation of purified optical isomers of desflurane. U.S. Patent 5 283 372, 1994 (Anaquest). Huang, G.G., Rozov, L.A., Halpem, D.F., Vernice, G.G. Preparation of the isoflurane enantiomers, J. Org. Chem. 58:7382-7387, 1993. Two patents (Young, J.W., Brandt, S. U.S. 5 114 714, 1992, and U.S. 5 114 715, 1992; filing date 11/29/90) have been issued to Sepracor (Marlborough, MA) claiming the synthesis and use of optically enriched isoflurane and desflurane. These patents, both of which are entirely devoid of experimental detail, physical characterization, and pharmacological data, were filed after Ohmeda's (formerly Anaquest) patent application (USSN 07/ 550,417; filed 7/10/90) describing full physical characterization and pharmacological testing of the enantiomers of isoflurane.
13. Kawa, H., Yamaguchi, F., Ishikawa, N. Optically active perfluoro-2-isopropoxypropionic acid: A novel derivatizing agent for gas chromatographic analysis. Chem. Lett. 745-748, 1982.
14. (a) Rozov, L.A., Ramig, K. Asymmetric preparation of 1,2,2,2-tetrafluoroethyl methyl ether, and intermediate in the synthesis of volatile anesthetics. Tetrahedron Lett. 35:4501-4504, 1994.
15. (b) Doyle, T.R., Vogl, O. Bromochlorofluoromethane and deutenobromochlorofluoromethane of high optical purity. J. Am. Chem. Soc. 111:8510-8511, 1989.
16. (c) Rozov, L.A., Rafalko, P.W., Evans, S.M., Brockunier, L., Ramig, K. Asymmetric synthesis of the volatile anesthetic 1,2,2,2-tetrafluoroethyl chlorofiuoromethyl ether using a stereospecific decarboxylation of unusual stereochemical outcome. J. Org. Chem. 60:1319-1325, 1995.
17. Henne, A.L., Whaley, A.M., Stevenson, J.K. A new method of synthesizing organic 1,1,1-trifluorides. J. Am. Chem. Soc. 63:3478-3479, 1941.
18. Park, J.D., Sweeney, W.M., Lacher, J.R. The addition of alkanols to 1,1,2-trichloro-3,3,3-trifluoropropene-some corrective data. J. Org. Chem. 21:1035-1036, 1956.
19. Park, J.D., Sweeney, W.M., Lacher, J.R. The stability of some fluorochloropropyl ethyl ethers. J. Org. Chem. 21:220-222, 1956.
20. 2O).
21. 2 is produced during halothane production. This indicates that deprotonation of the amide to give 12 is the initial process, followed by loss of HNCO, which may be the species which stereorandomly protonates the supposed organopotassium intermediate 13.
22. Meinwald, J., Thompson, W.R., Pearson, D.L., König, W.A., Runge, T., Francke, W. Inhalational anesthetics stereochemistry: Optical resolution of halothane, enflurane, and isoflurane. Science, 251:560-561, 1991.
23. Cram, D.J., Wingrove, A.S. Electrophilic substitution at saturated carbon. XVIII. Carbon as leaving group in generation of optically active α-sulfonylcarbanions. J. Am. Chem. Soc. 85:1100-1107, 1963. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XII. Sterochemical capabilities of alkyl-substituted acetonitrile anions. J. Am. Chem. Soc. 83:2363-2367. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XI. Steric course of the base-catalyzed decarboxylation reaction. J. Am. Chem. Soc. 83:2354-2362, 1961.
24. Cram, D.J., Wingrove, A.S. Electrophilic substitution at saturated carbon. XVIII. Carbon as leaving group in generation of optically active α-sulfonylcarbanions. J. Am. Chem. Soc. 85:1100-1107, 1963. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XII. Sterochemical capabilities of alkyl-substituted acetonitrile anions. J. Am. Chem. Soc. 83:2363-2367. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XI. Steric course of the base-catalyzed decarboxylation reaction. J. Am. Chem. Soc. 83:2354-2362, 1961.
25. Cram, D.J., Wingrove, A.S. Electrophilic substitution at saturated carbon. XVIII. Carbon as leaving group in generation of optically active α-sulfonylcarbanions. J. Am. Chem. Soc. 85:1100-1107, 1963. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XII. Sterochemical capabilities of alkyl-substituted acetonitrile anions. J. Am. Chem. Soc. 83:2363-2367. Cram, D.J., Haberfield, P. Electrophilic substitution at saturated carbon. XI. Steric course of the base-catalyzed decarboxylation reaction. J. Am. Chem. Soc. 83:2354-2362, 1961.